Search

Your search keyword '"Moll van Charante, Eric P"' showing total 547 results
Start Over Author "Moll van Charante, Eric P"
547 results on '"Moll van Charante, Eric P"'

53. Telephone and Smartphone-Based Interventions for Cognitive and Cardio-Metabolic Health in Middle-Aged and Older Adults: A Systematic Review

Author

Andre,Laurine, Giulioli,Caroline, Piau,Antoine, Bongard,Vanina, Richard,Edo, Moll van Charante,Eric P, Coley,Nicola, and Andrieu,Sandrine

Subjects
Clinical Interventions in Aging
Abstract

Laurine Andre,1,2 Caroline Giulioli,1 Antoine Piau,1,2 Vanina Bongard,1,3 Edo Richard,4,5 Eric P Moll van Charante,4,6 Nicola Coley,1,3 Sandrine Andrieu1,3 On behalf of the PRODEMOS consortium1Center for Epidemiology and Research in Population Health (CERPOP), University of Toulouse, INSERM UMR1295, UPS, Toulouse, France; 2Pole de Geriatrie, University Hospital of Toulouse, UPS, Toulouse, F-31400, France; 3Department of Epidemiology and Public Health, Toulouse University Hospital, Toulouse, France; 4Department of Public and Occupational Health, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; 5Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands; 6Department of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam, 1100DD, the NetherlandsCorrespondence: Laurine Andre, INSERM-University of Toulouse UMR1295, Pole de geriatrie, University Hospital of Toulouse, UPS, 37 allées Jules Guesde, Toulouse, F-31000, France, Tel +33562004344, Email laur.andre@hotmail.comPurpose: Dementia and cardio-metabolic diseases share many risk factors. Management of these risk factors could contribute to successful aging, including the prevention of cardio-metabolic disease and dementia. The increasing use of smartphones offers an opportunity for remote preventive interventions. We provided a systematic review of telephone and smartphone-based interventions targeting the prevention of cognitive decline, dementia cardio-metabolic diseases or their risk factors among adults aged over 50 years.Patients and Methods: We searched Pubmed and the International Clinical Trials Registry Platform for experimental studies. We used the Cochrane risk-of-bias tool (Version 2) for randomized trials or TREND (Transparent Reporting of Evaluations with Nonrandomized Designs) checklists to assess study quality for completed studies.Results: We analyzed 21 completed (3 for cognition, 18 for cardio-metabolic outcomes) and 50 ongoing studies (23 for cognition, 27 for cardio-metabolic outcomes). Smartphone interventions were used in 26 studies (3 completed, 23 ongoing). Other interventions involved telephone vocal support and text messaging. Few studies were at low risk of bias. There were heterogeneous cognitive and cardio-metabolic outcomes. The highest quality studies found no significant effects on cognition, and inconsistent results for HbA1c, blood pressure or physical activity. The lower quality-studies found effects on global cognition, working memory, memory and language and inconsistent results for clinical, biological or behavioral cardio-metabolic outcomes.Conclusion and Implications: Despite the large number of commercially available mobile health applications, the magnitude of the scientific evidence base remains very limited. Based on published studies, the added value of telephone and smartphone tools for the prevention of cardio-metabolic diseases, cognitive decline or dementia is currently uncertain, but, there are several ongoing studies expected to be completed in the coming years.Keywords: aging, telephone, smartphone, cognition, dementia, cardio, vascular outcomes

Published
2022

55. Cardiovascular risk profile after a complicated pregnancy across ethnic groups: the HELIUS study

Author

Burger, Renée J, primary, Gordijn, Sanne J, additional, Bolijn, Renee, additional, Reilingh, Annemarie, additional, Moll Van Charante, Eric P, additional, Van Den Born, Bert-Jan H, additional, De Groot, Christianne J M, additional, Ravelli, Anita C J, additional, Galenkamp, Henrike, additional, Van Valkengoed, Irene G M, additional, and Ganzevoort, Wessel, additional

Published
2022
Full Text
View/download PDF

57. Needs and views on healthy lifestyles for the prevention of dementia and the potential role for mobile health (mHealth) interventions in China: a qualitative study

Author

Zhang, Jinxia, primary, Eggink, Esmé, additional, Zhang, Xiaoyu, additional, Li, Xingming, additional, Jiang, Bin, additional, Liu, Hongmei, additional, Ge, Siqi, additional, Zhang, Wei, additional, Lyu, Jihui, additional, Niu, Yixuan, additional, Yu, Yueyi, additional, Hou, Haifeng, additional, Xu, Xizhu, additional, Ye, Xiaoyan, additional, Wang, Wenzhi, additional, Terlou, Ruben, additional, Richard, Edo, additional, Wang, Wei, additional, Wang, Youxin, additional, Moll van Charante, Eric P, additional, and Song, Manshu, additional

Published
2022
Full Text
View/download PDF

64. Severe Fatigue in the First Year Following SARS-CoV-2 Infection: A Prospective Cohort Study

Author

Verveen, Anouk, Wynberg, Elke, van Willigen, Hugo D. G., Boyd, Anders, de Jong, Menno D., de Bree, Godelieve, Davidovich, Udi, Lok, Anja, Moll van Charante, Eric P., Knoop, Hans, Prins, Maria, Nieuwkerk, Pythia, Agard, Ivette, Ayal, Jane, Cavdar, Floor, Craanen, Marianne, Deuring, Annemarieke, van Dijk, Annelies, Ersan, Ertan, del Grande, Laura, Hartman, Joost, Koedoot, Nelleke, Leenstra, Tjalling, Lebbink, Romy, Loomans, Dominique, Makowska, Agata, du Maine, Tom, de Man, Ilja, Matser, Amy, van der Meij, Lizenka, van Polanen, Marleen, Oud, Maria, Reid, Clark, Storey, Leeann, van Wijk, Marc, van den Aardweg, Joost, van Assem, Joyce, van Beek, Marijne, Blankert, Thyra, Dijkstra, Maartje, Figaroa, Orlane, Frenkel, Leah, van Gils, Marit, van Haga, Jelle, Han, Xiaochuan, Harskamp-Holwerda, Agnes, Hazenberg, Mette, Hidad, Soemeja, de Jong, Nina, Kootstra, Neeltje, Kuijt, Lara, Russell, Colin, van der Straten, Karlijn, van der Veen, Annelou, Verkaik, Bas, Visser, Gerben-Rienk, Graduate School, Medical Psychology, APH - Mental Health, Medical Microbiology and Infection Prevention, Infectious diseases, APH - Methodology, APH - Global Health, AII - Infectious diseases, APH - Aging & Later Life, Adult Psychiatry, ANS - Mood, Anxiety, Psychosis, Stress & Sleep, General practice, Public and occupational health, ACS - Diabetes & metabolism, APH - Health Behaviors & Chronic Diseases, APH - Personalized Medicine, Pulmonology, ACS - Pulmonary hypertension & thrombosis, AMS - Sports, Experimental Immunology, and Pulmonary medicine

Subjects
predictors, COVID-19, fatigue, macromolecular substances, persistence, infection
Abstract

Background: Severe fatigue can persist for months after coronavirus disease 2019 (COVID-19) onset. This longitudinal study describes fatigue severity and its determinants up to 12 months after illness onset across the full spectrum of COVID-19 severity. Methods: RECoVERED, a prospective cohort study in Amsterdam, the Netherlands, enrolled participants aged≥16 years after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnosis. Fatigue was measured using the validated Short Fatigue Questionnaire (SFQ; range 4-28) at months 1, 3, 6, 9, and 12 of follow-up. Fatigue severity was modeled over time using mixed-effects linear regression. Determinants of severe fatigue (SFQ≥18) at 6 months since illness onset (ie, persistent fatigue) were identified using logistic regression. Results: Between May 2020 and July 2021, 303 participants completed at least 1 fatigue questionnaire. Twelve months after illness onset, 17.4% (95% CI, 6.7% to 38.3%), 21.6% (95% CI, 11.2% to 37.7%), and 44.8% (95% CI, 28.0% to 62.9%) of participants with mild, moderate, and severe/critical COVID-19 (World Health Organization definition), respectively, experienced severe fatigue. When adjusting for age and sex, having≥3 comorbidities (P=.007), severe/critical COVID-19 (P=.002), low mood (P

Published
2022
Full Text
View/download PDF

66. Association of Systolic Blood Pressure With Dementia Risk and the Role of Age, U-Shaped Associations, and Mortality

Author

van Dalen, Jan Willem, Brayne, Carol, Crane, Paul K., Fratiglioni, Laura, Larson, Eric B., Lobo, Antonio, Lobo, Elena, Marcum, Zachary A., Moll van Charante, Eric P., Qiu, Chengxuan, Riedel-Heller, Steffi G., Röhr, Susanne, Rydén, Lina, Skoog, Ingmar, van Gool, Willem A., Richard, Edo, van Dalen, Jan Willem, Brayne, Carol, Crane, Paul K., Fratiglioni, Laura, Larson, Eric B., Lobo, Antonio, Lobo, Elena, Marcum, Zachary A., Moll van Charante, Eric P., Qiu, Chengxuan, Riedel-Heller, Steffi G., Röhr, Susanne, Rydén, Lina, Skoog, Ingmar, van Gool, Willem A., and Richard, Edo

Abstract

IMPORTANCE The optimal systolic blood pressure (SBP) to minimize the risk of dementia in older age is unknown. OBJECTIVE To investigate whether the association between SBP and dementia risk is U-shaped and whether age and comorbidity play a role in this association. DESIGN, SETTING, AND PARTICIPANTS This cohort study used an individual participant data approach to analyze 7 prospective, observational, population-based cohort studies that were designed to evaluate incident dementia in older adults. These studies started between 1987 and 2006 in Europe and the US. Participants had no dementia diagnosis and had SBP and/or diastolic blood pressure (BP) data at baseline and incident dementia status during follow-up. Data analysis was conducted from November 7, 2019, to October 3, 2021. Exposures Baseline systolic BP. MAIN OUTCOMES AND MEASURES All-cause dementia (defined using Diagnostic and Statistical Manual of Mental Disorders [Third Edition Revised] or Diagnostic and Statistical Manual of Mental Disorders [Fourth Edition] and established at follow-up measurements or in clinical practice), mortality, and combined dementia and mortality were the outcomes. Covariates included baseline antihypertensive medication use, sex, educational level, body mass index, smoking status, diabetes, stroke history, myocardial infarction history, and polypharmacy. Cox proportional hazards regression models were used, and nonlinear associations were explored using natural splines. RESULTS The study analyzed 7 cohort studies with a total of 17 286 participants, among whom 10 393 were women (60.1%) and the mean (SD) baseline age was 74.5 (7.3) years. Overall, dementia risk was lower for individuals with higher SBP, with the lowest risk associated with an SBP of approximately 185 mm Hg (95% CI, 161-230 mm Hg; P = .001). Stratified by overlapping 10-year baseline age groups, the lowest dementia risk was observed at somewhat lower systolic BP levels in those older than 75 years (158 [95% CI, 1

Published
2022
Full Text
View/download PDF

67. Low Values for Blood Pressure, BMI, and Non-HDL Cholesterol and the Risk of Late-Life Dementia

Author

Brok, M.G.H.E. den, Eggink, E., Hoevenaar-Blom, Marieke P., Gool, Willem A. van, Moll van Charante, Eric P., Richard, E., Dalen, J. van, Brok, M.G.H.E. den, Eggink, E., Hoevenaar-Blom, Marieke P., Gool, Willem A. van, Moll van Charante, Eric P., Richard, E., and Dalen, J. van

Abstract

Contains fulltext : 283847.pdf (Publisher’s version ) (Open Access)

Published
2022

68. Needs and views on healthy lifestyles for the prevention of dementia and the potential role for mobile health (mHealth) interventions in China: a qualitative study

Author

Zhang, Jinxia, Eggink, E., Zhang, Xiaoyu, Li, Xingming, Jiang, B., Liu, Hongmei, Ge, Siqi, Richard, E., Moll van Charante, Eric P., Song, Manshu, Zhang, Jinxia, Eggink, E., Zhang, Xiaoyu, Li, Xingming, Jiang, B., Liu, Hongmei, Ge, Siqi, Richard, E., Moll van Charante, Eric P., and Song, Manshu

Abstract

Item does not contain fulltext

Published
2022

69. Additional file 1 of Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study

Author

Verveen, Anouk, Wynberg, Elke, van Willigen, Hugo D. G., Davidovich, Udi, Lok, Anja, Moll van Charante, Eric P., de Jong, Menno D., de Bree, Godelieve, Prins, Maria, Knoop, Hans, and Nieuwkerk, Pythia T.

Abstract

Additional file 1: Table S1. Comparison of demographic and clinical characteristics of RECoVERED study participants who did and did not complete at least 1 HRQL questionnaire.

Published
2022
Full Text
View/download PDF

72. Association of Systolic Blood Pressure With Dementia Risk and the Role of Age, U-Shaped Associations, and Mortality

Author

van Dalen, Jan Willem, primary, Brayne, Carol, additional, Crane, Paul K., additional, Fratiglioni, Laura, additional, Larson, Eric B., additional, Lobo, Antonio, additional, Lobo, Elena, additional, Marcum, Zachary A., additional, Moll van Charante, Eric P., additional, Qiu, Chengxuan, additional, Riedel-Heller, Steffi G., additional, Röhr, Susanne, additional, Rydén, Lina, additional, Skoog, Ingmar, additional, van Gool, Willem A., additional, and Richard, Edo, additional

Published
2022
Full Text
View/download PDF

77. SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020

Author

Coyer, Liza, primary, Boyd, Anders, additional, Schinkel, Janke, additional, Agyemang, Charles, additional, Galenkamp, Henrike, additional, Koopman, Anitra D M, additional, Leenstra, Tjalling, additional, Moll van Charante, Eric P, additional, van den Born, Bert-Jan H, additional, Lok, Anja, additional, Verhoeff, Arnoud, additional, Zwinderman, Aeilko H, additional, Jurriaans, Suzanne, additional, van Vught, Lonneke A, additional, Stronks, Karien, additional, and Prins, Maria, additional

Published
2022
Full Text
View/download PDF

82. Het levenslange risico op dementie: Een berekening op basis van individueel gekoppelde landelijke data

Author

Klijs, Bart, Mitratza, Marianna, Harteloh, Peter P. M., Moll van Charante, Eric P., Richard, Edo, Nielen, Markus M. J., Kunst, Anton E., APH - Global Health, APH - Health Behaviors & Chronic Diseases, General practice, Public and occupational health, ACS - Diabetes & metabolism, APH - Personalized Medicine, Neurology, 10 Public Health & Methodologie, APH - Mental Health, and APH - Methodology

Published
2021

83. Design and Development of a Mobile Health (mHealth) Platform for Dementia Prevention in the Prevention of Dementia by Mobile Phone Applications (PRODEMOS) Project

Author

Hafdi, Melanie, primary, Eggink, Esmé, additional, Hoevenaar-Blom, Marieke P., additional, Witvliet, M. Patrick, additional, Andrieu, Sandrine, additional, Barnes, Linda, additional, Brayne, Carol, additional, Brooks, Rachael, additional, Coley, Nicola, additional, Georges, Jean, additional, van der Groep, Abraham, additional, van Marwijk, Harm, additional, van der Meijden, Mark, additional, Song, Libin, additional, Song, Manshu, additional, Wang, Youxin, additional, Wang, Wenzhi, additional, Wang, Wei, additional, Wimo, Anders, additional, Ye, Xiaoyan, additional, Moll van Charante, Eric P., additional, and Richard, Edo, additional

Published
2021
Full Text
View/download PDF

86. Cardiovascular risk profile after a complicated pregnancy across ethnic groups: the HELIUS study

Author

Burger, Renée J, Gordijn, Sanne J, Bolijn, Renee, Reilingh, Annemarie, Moll Van Charante, Eric P, Van Den Born, Bert-Jan H, De Groot, Christianne J M, Ravelli, Anita C J, Galenkamp, Henrike, Van Valkengoed, Irene G M, and Ganzevoort, Wessel

Abstract

Women of different ethnic backgrounds who had pregnancy complications (high blood pressure or diabetes during pregnancy, or who delivered their baby too early) have a higher risk of heart disease later in life. Screening for a high risk of heart disease is important because interventions may help to prevent heart disease. Currently, general practitioners use several criteria to select women for screening, such as heart disease among close relatives or smoking. In our study in women in whom these ‘traditional’ criteria for screening were measured, the pregnancy complications did not help to find more women with a high risk. Yet, pregnancy complications may be a signal for both patients and healthcare professionals to regularly consider the need for screening.Women who had high blood pressure in pregnancy or delivered their baby too early had up to two times more often chronic hypertension or kidney disease later in life. Women who had diabetes in pregnancy, had up to eight times more type 2 diabetes later in life.Women of South-Asian Surinamese, African Surinamese, and Ghanaian origin living in the Netherlands more often had pregnancy complications and cardiovascular risk factors than women with a Dutch background.Graphical AbstractPregnancy complications and cardiovascular risk factors.

Published
2023
Full Text
View/download PDF

87. Screening op dementie bij eerstegeneratiemigranten

Author

van de Vorst, Irene E., van Campen, J. Jos P.C.M., Moll van Charante, Eric P., Schmand, B. Ben A., Goudsmit, Miriam, General practice, Public and occupational health, ACS - Diabetes & metabolism, APH - Personalized Medicine, APH - Health Behaviors & Chronic Diseases, and Medical Psychology

Abstract

The number of patients with dementia is increasing over time. There is evidence that the prevalence in ethnic minority groups is even higher. Diagnosing dementia in first generation non-western migrants is often difficult due to language and cultural barriers, low education, and illiteracy. In this article we recommend the use of two validated screening tools (the RUDAS, Rowland Universal Dementia assessment scale and the IQCODE, Informant Questionnaire of Cognitive Decline in the elderly) elucidated by two case descriptions.

Published
2021

88. Effects of antihypertensives with and without IL-6 lowering properties on long-term blood pressure control: The prospective HELIUS cohort

Author

Batuo, Hillmann, van der Linden, Eva, Galenkamp, Henrike, Moll van Charante, Eric, Born, Bert-Jan van der, and Chilunga, Felix P.

Abstract

Chronic inflammation is a well-recognized contributor to hypertension pathogenesis. However, the role of targeting inflammation in hypertension treatment, particularly through modulation of inflammatory markers like interleukin-6 (IL-6), remains less understood. We investigated the effects of antihypertensive medications with and without IL-6-lowering properties on long-term blood pressure (BP) control in a multi-ethnic cohort in the Netherlands.

Published
2025
Full Text
View/download PDF

91. Design and development of a mobile health (mHealth) platform for dementia prevention in the prevention of dementia by mobile phone applications (PRODEMOS) project

Author

Hafdi, Melanie, Eggink, Esmé, Hoevenaar-Blom, Marieke P., Witvliet, M. Patrick, Andrieu, Sandrine, Barnes, Linda, Brayne, Carol, Brooks, Rachael, Coley, Nicola, Georges, Jean, van der Groep, Abraham, van Marwijk, Harm, van der Meijden, Mark, Song, Libin, Song, Manshu, Wang, Youxin, Wang, Wenzhi, Wang, Wei, Wimo, Anders, Ye, Xiaoyan, Moll van Charante, Eric P., Richard, Edo, PRODEMOS consortium, Hafdi, Melanie, Eggink, Esmé, Hoevenaar-Blom, Marieke P., Witvliet, M. Patrick, Andrieu, Sandrine, Barnes, Linda, Brayne, Carol, Brooks, Rachael, Coley, Nicola, Georges, Jean, van der Groep, Abraham, van Marwijk, Harm, van der Meijden, Mark, Song, Libin, Song, Manshu, Wang, Youxin, Wang, Wenzhi, Wang, Wei, Wimo, Anders, Ye, Xiaoyan, Moll van Charante, Eric P., Richard, Edo, and PRODEMOS consortium

Abstract

Background: Mobile health (mHealth) has the potential to bring preventive healthcare within reach of populations with limited access to preventive services, by delivering personalized support at low cost. Although numerous mHealth interventions are available, very few have been developed following an evidence-based rationale or have been tested for efficacy. This article describes the systematic development of a coach-supported mHealth application to improve healthy lifestyles for the prevention of dementia and cardiovascular disease in the United Kingdom (UK) and China. Methods: Development of the Prevention of Dementia by Mobile Phone applications (PRODEMOS) platform built upon the experiences with the Healthy Aging Through Internet Counseling in the Elderly (HATICE) eHealth platform. In the conceptualization phase, experiences from the HATICE trial and needs and wishes of the PRODEMOS target population were assessed through semi-structured interviews and focus group sessions. Initial technical development of the platform was based on these findings and took place in consecutive sprint sessions. Finally, during the evaluation and adaptation phase, functionality and usability of the platform were evaluated during pilot studies in UK and China. Results: The PRODEMOS mHealth platform facilitates self-management of a healthy lifestyle by goal setting, progress monitoring, and educational materials on healthy lifestyles. Participants receive remote coaching through a chat functionality. Based on lessons learned from the HATICE study and end-users, we made the intervention easy-to-use and included features to personalize the intervention. Following the pilot studies, in which in total 77 people used the mobile application for 6 weeks, the application was made more intuitive, and we improved its functionalities. Conclusion: Early involvement of end-users in the development process and during evaluation phases improved acceptability of the mHealth intervention. The actual

Published
2021

92. Prevention of dementia using mobile phone applications (PRODEMOS): Protocol for an international randomised controlled trial

Author

Eggink, Esmé, Hafdi, Melanie, Hoevenaar-Blom, Marieke P., Song, Manshu, Andrieu, Sandrine, Barnes, Linda E., Birck, Cindy, Brooks, Rachael L., Coley, Nicola, Ford, Elizabeth, Georges, Jean, van der Groep, Abraham, Van Gool, Willem A., Handels, Ron, Hou, Haifeng, Li, Dong, Liu, Hongmei, Lyu, Jihui, van Marwijk, Harm, van der Meijden, Mark, Niu, Yixuan, Sadhwani, Shanu, Wang, Wenzhi, Wang, Youxin, Wimo, Anders, Ye, Xiaoyan, Yu, Yueyi, Zeng, Qiang, Wang, Wei, Brayne, Carol, Moll van Charante, Eric P., Richard, Edo, Eggink, Esmé, Hafdi, Melanie, Hoevenaar-Blom, Marieke P., Song, Manshu, Andrieu, Sandrine, Barnes, Linda E., Birck, Cindy, Brooks, Rachael L., Coley, Nicola, Ford, Elizabeth, Georges, Jean, van der Groep, Abraham, Van Gool, Willem A., Handels, Ron, Hou, Haifeng, Li, Dong, Liu, Hongmei, Lyu, Jihui, van Marwijk, Harm, van der Meijden, Mark, Niu, Yixuan, Sadhwani, Shanu, Wang, Wenzhi, Wang, Youxin, Wimo, Anders, Ye, Xiaoyan, Yu, Yueyi, Zeng, Qiang, Wang, Wei, Brayne, Carol, Moll van Charante, Eric P., and Richard, Edo

Abstract

Introduction Profiles of high risk for future dementia are well understood and are likely to concern mostly those in low-income and middle-income countries and people at greater disadvantage in high-income countries. Approximately 30%-40% of dementia cases have been estimated to be attributed to modifiable risk factors, including hypertension, smoking and sedentary lifestyle. Tailored interventions targeting these risk factors can potentially prevent or delay the onset of dementia. Mobile health (mHealth) improves accessibility of such prevention strategies in hard-to-reach populations while at the same time tailoring such approaches. In the current study, we will investigate the effectiveness and implementation of a coach-supported mHealth intervention, targeting dementia risk factors, to reduce dementia risk. Methods and analysis The prevention of dementia using mobile phone applications (PRODEMOS) randomised controlled trial will follow an effectiveness-implementation hybrid design, taking place in the UK and China. People are eligible if they are 55-75 years old, of low socioeconomic status (UK) or from the general population (China); have ≥ 2 dementia risk factors; and own a smartphone. 2400 participants will be randomised to either a coach-supported, interactive mHealth platform, facilitating self-management of dementia risk factors, or a static control platform. The intervention and follow-up period will be 18 months. The primary effectiveness outcome is change in the previously validated Cardiovascular Risk Factors, Ageing and Incidence of Dementia dementia risk score. The main secondary outcomes include improvement of individual risk factors and cost-effectiveness. Implementation outcomes include acceptability, adoption, feasibility and sustainability of the intervention. Ethics and dissemination The PRODEMOS trial is sponsored in the UK by the University of Cambridge and is granted ethical approval by the London - Brighton and Sussex Research Ethics Commit

Published
2021

93. Prevention of dementia using mobile phone applications (PRODEMOS): protocol for an international randomised controlled trial

Author

Eggink, Esmé, primary, Hafdi, Melanie, additional, Hoevenaar-Blom, Marieke P, additional, Song, Manshu, additional, Andrieu, Sandrine, additional, Barnes, Linda E, additional, Birck, Cindy, additional, Brooks, Rachael L, additional, Coley, Nicola, additional, Ford, Elizabeth, additional, Georges, Jean, additional, van der Groep, Abraham, additional, van Gool, Willem A, additional, Handels, Ron, additional, Hou, Haifeng, additional, Li, Dong, additional, Liu, Hongmei, additional, Lyu, Jihui, additional, van Marwijk, Harm, additional, van der Meijden, Mark, additional, Niu, Yixuan, additional, Sadhwani, Shanu, additional, Wang, Wenzhi, additional, Wang, Youxin, additional, Wimo, Anders, additional, Ye, Xiaoyan, additional, Yu, Yueyi, additional, Zeng, Qiang, additional, Zhang, Wei, additional, Wang, Wei, additional, Brayne, Carol, additional, Moll van Charante, Eric P, additional, and Richard, Edo, additional

Published
2021
Full Text
View/download PDF

97. Needs and views on healthy lifestyles for the prevention of dementia through mobile health (mHealth) interventions in China: a qualitative study. (Preprint)

Author

Zhang, Jinxia, primary, Eggink, Esmé, additional, Zhang, Xiaoyu, additional, Li, Xingming, additional, Jiang, Bin, additional, Liu, Hongmei, additional, Ge, Siqi, additional, Zhang, Wei, additional, Lyu, Jihui, additional, Niu, Yixuan, additional, Yu, Yueyi, additional, Hou, Haifeng, additional, Xu, Xizhu, additional, Ye, Xiaoyan, additional, Wang, Wenzhi, additional, Terlou, Ruben, additional, Richard, Edo, additional, Wang, Wei, additional, Wang, Youxin, additional, Moll van Charante, Eric P, additional, and Song, Manshu, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results